Pacer Advisors, Inc. Galapagos Nv Transaction History

Pacer Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$51.32 - $68.5 $14,369 - $19,180	-280 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$47.03 - $57.12 $6,584 - $7,996	-140 Reduced 33.33%	280 $15,000
Q3 2021 Oct 15, 2021	SELL	$52.17 - $70.2 $27,024 - $36,363	-518 Reduced 55.22%	420 $22,000
Q2 2021 Jul 21, 2021	BUY	$68.86 - $83.34 $6,886 - $8,334	100 Added 11.93%	938 $65,000
Q1 2021 Apr 05, 2021	SELL	$76.15 - $111.94 $6,396 - $9,402	-84 Reduced 9.11%	838 $65,000
Q4 2020 Jan 20, 2021	BUY	$96.85 - $148.25 $44,938 - $68,788	464 Added 101.31%	922 $91,000
Q3 2020 Oct 19, 2020	BUY	$122.47 - $213.56 $56,091 - $97,810	458 New	458 $65,000
Q1 2020 Apr 23, 2020	SELL	$143.0 - $274.03 $342,199 - $655,753	-2,393 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$146.12 - $215.82 $154,156 - $227,690	1,055 Added 78.85%	2,393 $495,000
Q3 2019 Oct 10, 2019	BUY	$130.44 - $187.64 $174,528 - $251,062	1,338 New	1,338 $204,000

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.93B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.